Filing Analysis
Regulation FD Disclosure
Filed Mar 04, 2026
LOW
Cellectar Biosciences reported its financial results for the full year ended December 31, 2025, and provided a general corporate update via a press release.
Key Facts
- The report was filed on March 4, 2026, covering the fiscal year ended December 31, 2025.
- The company furnished a press release as Exhibit 99.1.
- The filing was made under Item 2.02 (Results of Operations and Financial Condition).
Disclaimer: This analysis is generated by AI and is for informational purposes only.
It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities.
Always review the original SEC filings and consult a financial advisor before making investment decisions.